Warren Averett Asset Management, LLC Gilead Sciences, Inc. Transaction History
Warren Averett Asset Management, LLC
- $9.72 Billion
- Q3 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 22,901 shares of GILD stock, worth $2.84 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
22,901
Previous 36,384
37.06%
Holding current value
$2.84 Million
Previous $4.03 Million
36.97%
% of portfolio
0.03%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
2,408Shares Held
1.01BCall Options Held
8.51MPut Options Held
7.32M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...